Merrimack Pharmaceuticals Inc – Plans of Reorganization, Merger, Acquisition or Similar – BamSEC

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

SEC EDGAR

Plans of Reorganization, Merger, Acquisition or Similar Filter

from 8-K 53 pages Asset Purchase Agreement by and Between Celator Pharmaceuticals, Inc. and Merrimack Pharmaceuticals, Inc. Dated as of March 27, 2020

from 8-K 3 pages Amendment No. 2 to Asset Purchase Agreement

from 8-K 2 pages Amendment No. 1 to Asset Purchase Agreement

from 8-K 52 pages Asset Purchase Agreement by and Between 14ner Oncology, Inc. and Merrimack Pharmaceuticals, Inc. Dated as of May 28, 2019

from DEFA14A 82 pages Asset Purchase and Sale Agreement Between Merrimack Pharmaceuticals, Inc., a Delaware Corporation; and Ipsen S.A., a Société Anonyme; Dated as of January 7, 2017

from 8-K 82 pages Asset Purchase and Sale Agreement Between Merrimack Pharmaceuticals, Inc., a Delaware Corporation; and Ipsen S.A., a Société Anonyme; Dated as of January 7, 2017